ECM
TEVA icon

Ensemble Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Ensemble Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-39,145
Closed -$1.48M – 52
2013
Q3 		$1.48M Sell
39,145
-53,125
-58% -$2.07M 0.65% 32
2013
Q2 		$3.62M Buy
+92,270
New +$3.59M 1.68% 24

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ensemble Capital Management's TEVA Position: Q4 2013 in Review

Ensemble Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2013, closing a stake of 39,145 shares — an estimated $1.48M sold.

Ensemble Capital Management first reported a position in TEVA in Q2 2013 and held it in 2 quarters. The position peaked at $3.62M in Q2 2013. 728 funds tracked by Wall St. Rank hold TEVA as of Q4 2013.

  • Ensemble Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Ensemble Capital Management sold 39,145 Teva Pharmaceuticals shares in Q4 2013, an estimated $1.48M.
  • Ensemble Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • Ensemble Capital Management's Teva Pharmaceuticals position peaked at $3.62M in Q2 2013.
  • 728 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2013.

Based on Ensemble Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.